Which Structure is Highlighted Prostatic Urethra? What to Know

The structure highlighted when the prostatic urethra is referenced is the segment of the urethra that runs directly through the prostate gland. It is the widest and most dilatable part of the male urethra, and it sits between the bladder and the external urethral sphincter. Everything below the prostate — the membranous and spongy urethra — is narrower and less flexible.

That location matters more than it might seem. Because the prostate wraps around this section of the urinary tube, any enlargement or inflammation of the gland can press inward and change how urine flows. This is why the prostatic urethra comes up so often in discussions of benign prostatic hyperplasia (BPH), prostate surgery, and urinary symptoms in men over 40.

What Is the Prostatic Urethra and Where Is It Located?

The male urethra is divided into four named segments based on the anatomy it passes through. The prostatic urethra is the first of those segments, beginning at the internal urethral orifice at the base of the bladder and ending at the superior fascia of the urogenital diaphragm, where the membranous urethra begins.

It is roughly 3 to 4 centimeters long in most adult men. The prostate gland surrounds it on all sides, which is why the two structures are described together so often in anatomy and urology.

A key structural feature is a raised ridge on the posterior wall called the urethral crest. On either side of this crest are shallow depressions called the prostatic sinuses, into which the ducts of the prostate gland open. The most prominent point of the crest is the colliculus seminalis (also called the verumontanum), where the two ejaculatory ducts empty into the urethra.

This arrangement explains why the prostatic urethra serves two systems at once — urinary and reproductive. It carries urine from the bladder, and it also receives semen from the ejaculatory ducts during ejaculation.

Why Does This Structure Matter in Prostate Conditions?

Because the prostate encircles the prostatic urethra, changes in the gland directly affect the tube. This is the anatomical reason BPH causes urinary symptoms. As the transition zone of the prostate enlarges — which is the pattern typical of benign growth — it compresses the prostatic urethra from the outside in.

That compression produces the classic lower urinary tract symptoms:

• Weak or interrupted urine stream
• Difficulty starting urination (hesitancy)
• Feeling of incomplete bladder emptying
• Frequent urination, especially at night (nocturia)
• Urgency

These symptoms are not caused by the prostate itself in a direct sense. They are caused by the prostate narrowing the tube that urine has to pass through. Understanding that distinction helps explain why treatments for BPH focus on either relaxing the muscle in the prostate or reducing the size of the gland.

Prostate cancer can also affect the prostatic urethra, though the relationship is different. Most prostate cancers begin in the peripheral zone — the outer part of the gland — which is farther from the urethra. That is one reason early prostate cancer often causes no urinary symptoms at all.

What Role Does the Prostatic Urethra Play in Ejaculation?

The prostatic urethra is the meeting point of the urinary and reproductive tracts. During ejaculation, sperm from the testicles and fluid from the seminal vesicles enter through the ejaculatory ducts at the colliculus seminalis. From there, the mixture passes through the prostatic urethra and then the rest of the urethra.

This dual function is why some prostate treatments affect ejaculation. Procedures that remove or alter tissue around the prostatic urethra can change whether semen is expelled normally or travels backward into the bladder — a condition called retrograde ejaculation. This is a well-documented outcome of certain BPH surgeries and some medications, not a rare complication.

The internal urethral sphincter, located at the bladder neck just above the prostatic urethra, plays a role here too. It closes during ejaculation to prevent urine from mixing with semen and to direct semen forward. When this sphincter or the surrounding prostate tissue is altered by surgery, that coordination can change.

How Is the Prostatic Urethra Evaluated Clinically?

Direct visualization of the prostatic urethra is done with a procedure called cystoscopy, in which a thin camera is passed through the urethra into the bladder. This allows a urologist to see the shape of the prostatic urethra, look for obstruction, and identify other abnormalities.

Urodynamic testing can measure how much pressure is needed to push urine through the prostatic urethra. This is sometimes used when the cause of symptoms is unclear or when surgery is being considered.

Imaging such as ultrasound can estimate prostate size and the amount of urine left in the bladder after voiding (post-void residual). A large post-void residual suggests the prostatic urethra is significantly obstructed, though the relationship between prostate size and symptom severity is not straightforward — some men with large prostates have few symptoms, and some with smaller prostates have many.

Prostate-specific antigen (PSA) testing is used to assess prostate cancer risk. It is not a direct measure of prostatic urethra function, though an enlarged prostate can raise PSA levels for reasons unrelated to cancer.

What Happens to the Prostatic Urethra During Prostate Surgery?

Most surgical treatments for BPH work by removing or reshaping the tissue of the prostate that is compressing the prostatic urethra. The goal is to widen the channel so urine can flow more freely.

Transurethral resection of the prostate (TURP) is one of the most established procedures. A resectoscope is passed through the urethra, and tissue is removed from the inside out, creating a wider opening through the prostatic urethra. Because the approach goes through the urethra, there is no external incision.

Other procedures use different mechanisms — lasers, steam, or implants — but the shared principle is reducing obstruction at the level of the prostatic urethra. Some newer minimally invasive options aim to preserve ejaculatory function better than traditional TURP, though the evidence on how well they compare across all outcomes is still developing.

After surgery, the prostatic urethra often remains wider than before, and urinary flow typically improves. However, outcomes vary. Some men continue to have symptoms, and some experience new ones such as incontinence or retrograde ejaculation. These risks are real and worth discussing with a urologist before any procedure.

How Does the Prostatic Urethra Compare to Other Urethral Segments?

The four segments of the male urethra differ in length, location, and function. The table below summarizes the key differences.

The prostatic urethra is distinctive because of its width and its dual role. No other segment receives reproductive duct openings, and no other segment is so directly influenced by a surrounding gland.

What Symptoms Suggest a Problem With the Prostatic Urethra?

Symptoms that point to obstruction or irritation at the level of the prostatic urethra include a weak stream, straining to urinate, a sensation of incomplete emptying, and needing to urinate frequently. Blood in the urine (hematuria) can also occur, though it has many possible causes and is not specific to the prostatic urethra.

These symptoms overlap with several other conditions, including urinary tract infection, bladder stones, urethral stricture, and neurological causes of bladder dysfunction. Having these symptoms does not mean the prostatic urethra is the source. A urologist can distinguish among these possibilities with examination and testing.

One point worth clarifying: the severity of urinary symptoms does not reliably indicate how enlarged the prostate is or how narrowed the prostatic urethra has become. Symptom scores and objective measures of obstruction often do not match closely. This is why clinical evaluation involves more than just asking how bad the symptoms feel.

Can Problems With the Prostatic Urethra Be Prevented?

There is no established way to prevent BPH or the urethral narrowing it causes. BPH is a common condition related to age and hormonal changes, and it affects a majority of men as they get older. Some lifestyle factors — such as maintaining a healthy weight and managing blood sugar — have been associated with lower risk in some studies, but the evidence is not strong enough to support specific prevention recommendations.

What can be done is early evaluation when symptoms appear. Treating significant obstruction before it leads to complications such as bladder stones, recurrent infections, or kidney damage is generally preferable to waiting. That said, mild BPH symptoms often do not require immediate treatment, and many men manage them with monitoring alone.

For prostate cancer, the picture is different. Screening decisions involve a conversation with a clinician about PSA testing, age, family history, and individual risk. The prostatic urethra itself is not the target of screening, but understanding its anatomy helps explain why early prostate cancer often produces no urinary symptoms.